| Financial Year |
March 31 2023 |
| Monetary Funds |
266,685,263.54 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
23,077,373.69 |
| Advances to Suppliers |
4,861,872.38 |
| Other Receivables |
8,434,029.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
37,988,916.38 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
12,064,538.12 |
| Total Current Assets |
353,111,993.63 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
8,304,963.99 |
| Investment Properties |
552,629,983.86 |
| Fixed Assetes |
1,636,419,749.22 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
31,309,622.86 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
158,916,081.58 |
| Deferred Income Tax Assets |
33,027,498.64 |
| Other Non-Current Assets |
114,538.88 |
| Sub-Total of Non-Current Assets |
2,439,097,158.08 |
| Total Assets |
2,792,209,151.71 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
59,693,557.10 |
| Accounts Received In Advance |
21,903,342.89 |
| Employee Compensation Payable |
50,858,381.52 |
| Taxes Payable |
20,544,171.56 |
| Interest Payable |
-- |
| Dividend Payable |
1,517,843.86 |
| Other payables |
404,561,804.04 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,566,044.30 |
| Other Current Liabilities |
2,136,096.61 |
| Sub-Total of Current Liabilities |
669,017,746.36 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
17,678,980.00 |
| Deferred Income Tax Liabilities |
13,466,008.99 |
| Other Non-Current Liabilities |
2,610,466.60 |
| Sub-Total of Non-Current Liabilities |
57,066,533.05 |
| Total Liabilities |
726,084,279.41 |
| Paid-In Capital(Or Share Stock) |
316,804,949.00 |
| Capital Surplus |
791,291,012.30 |
| Surplus Reserve |
627,704,273.57 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
216,932,721.51 |
| Minority Stockholder's Interest |
113,391,915.92 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,952,732,956.38 |
| Owner's Equity（Stockholder's Equity） |
2,066,124,872.30 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,792,209,151.71 |
